Protagenic Therapeutics
(NASDAQ) PTIX
Protagenic Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$5.16M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
PTIX News
PTIX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Protagenic Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
Barrett Evans
Website
www.protagenic.comHeadquarters
New York City, NY 10010, US
PTIX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
2%
Return on Capital
1%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$37.72K
Operating Income
$5.83M
EBITDA
$8.02M
Operating Cash Flow
$4.14M
Capital Expenditure
$3.00
Free Cash Flow
$4.14M
Cash & ST Invst.
$2.21M
Total Debt
$3.16M
Protagenic Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
+100.0%
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
1
N/A
Net Income
$2.21M
+242.3%
EBITDA
$925.10K
+40.0%
Quarterly Fundamentals
Net Cash
$943.26K
-151.3%
Accounts Receivable
$0.00
N/A
Inventory
$1.07K
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$3.16M
N/A
Return on Assets
-2.42%
N/A
Return on Invested Capital
1.24%
N/A
Free Cash Flow
$410.43K
+49.9%
Operating Cash Flow
$410.42K
+49.9%